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1. Introduction
  Scrub typhus is a vector borne zoonosis caused by the 
organism Oricntia tsutsugamushi (O. tsutsugamushi). This 
acute febrile illness is endemic in many countries in eastern 
and south-east Asia and northern Australia[1]. Trombiculid 
mites (Leptotrombidium deliense, L. palladium etc) are the 
natural hosts of the pathogen. The infected larval stages 
of mites (chiggers) inoculate humans (accidental hosts) 
while feeding. The pathogens multiply at the site of entry 
which later develops in to an eschar[2] and this is followed 
by a febrile illness, with many clinical manifestations. It is 
estimated that 1 million new cases appear annually and 1 
billion people are at risk of infection[3]. 
  The incidence of cases of scrub typhus has been increasing 
since the early eighties[4]. While some attribute this to the 
appearance of new strains of pathogens, it is also possible 
that cases were misdiagnosed or under-diagnosed in the 
past, thus underestimating the mortality and morbidity due 
to the disease. It is difficult to conclude whether this is an 
already existent yet unappreciated prevalence or a true 
rise in incidence[5-7].  For example, assessment of patients 
with prolonged undiagnosed fever in Southern India and 
Sri Lanka by serological examination have shown that 
a significant proportion (9.2%-37.5%) had evidence of 
current and past infection with scrub typhus[8,9]. 
  While in many instances a simple febrile illness, scrub 
typhus has potentially fatal outcome with multiple organ 
dysfunction in severe cases[10]. Estimates of mortality 
rates from scrub typhus lie between 0%-30% in untreated 
patients[11]. Clinical manifestations can be diverse, and this 
brief review summarizes the pathophysiology of the disease, 
the different clinical manifestations, and their relationship 
to prognosis.
2. Methods
  We searched PUBMED using the keywords ‘scrub typhus’ 
or ‘O. tsutsugamushi’ in any field. The search was restricted 
to articles published in English within the last 15 years 
(1994-2009) as they would contain more recent data. We 
screened all abstracts for relevance, i.e., data on clinical 
manifestations and presentations, pathophysiology, and 
prognosis (independent coding by three reviewers). Suitable 
data was available in 112 sources. Data sources included; 
reviews published in core clinical journals, cohort studies, 
interventional studies, clinical trials and cross sectional 
analyses. Hundred and one papers were reviewed from a 
selected 112 (90.2%).  
3. Pathophysiology
  O. tsutsugamushi survives in the wild in a cycle involving 
trombiculid mites (principal vectors) and other vertebrates 
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(small mammals and birds). Humans are accidental hosts for 
the pathogen. O. tsutsugamushi is different from rickettsia 
in its genetic makeup, cell wall structure and many authors 
now agree that it is an obligate intracellular gram negative 
bacterium[12]. The larval stage of the mites (chiggers) 
harbouring the bacterium, bite exposed individuals 
in vulnerable niches such as forests and mite infested 
undergrowth during occupational and recreational activities. 
Following the bite, the pathogen multiplies at the site of 
inoculation and subsequently induces local and systemic 
manifestations of infection[13].
  The severity of illness depends on both host and pathogen 
related factors. Pathogen related factors may be attributed 
to the fact that different strains (Karp, Gilliam etc.) of
O. tsutsugamushi may contribute differently to disease 
severity. Human hosts with G6PD deficiency are shown 
to have a worse prognosis than healthy individuals[14,15]. 
It is now established that the bacterium multiplies and 
disseminates within the human host and its principal 
target site is the endothelial cells. They have been located 
in endothelial cells of heart, lung, brain, liver, kidney, 
pancreas, skin and also isolated from macrophages of liver 
and spleen in post mortem samples[16]. Initially it was 
thought that the organism gains entry to the target organs 
through the lymphatic system. However in 2001, Walsh et 
al[17] have demonstrated the pathogen within mononuclear 
white blood cells in patients with acute infection, suggesting 
the possibility of a direct blood borne spread.
  The immune response induced by O. tsutsugamushi is a 
combination of humoral and cell mediated immunity. The 
rise of cytokines during an acute infection was demonstrated 
as far back as 1997 by Iwasaki et al[18]. In a small series of 
patients, they have shown a significant rise in macrophage 
colony stimulating factor (M-CSF), interferon gamma (IFN-毭)
and granulocyte colony stimulating factor (G-CSF). Only 
a few patients showed a rise in tumour necrosis factor
(TNF-毩) during the infection but it continued to rise during 
convalescence in those who had severe disease. These 
observations demonstrated that the macrophage and T 
lymphocyte response may be the driving factor in immunity 
against infection. More recently, de Fost et al[19] have 
demonstrated indirect evidence for cytotoxic lymphocyte 
(cytotoxic T cell and natural killer cell) activation during 
acute infection that may play a key role in destroying the 
infected host cells.
  The parasite has evolved to evade the immune mechanisms 
of the host. Given the high mortality rate of untreated 
disease, these mechanisms are of clinicopathological 
significance. Cho et al[20] showed that live O. tsutsugamushi 
down regulates the expression of the glycoprotein 96 (gp96) 
in infected macrophages and endothelial cells compared 
to non- infected cells in cell culture. This molecule is 
expressed in the endoplasmic reticulum of cells and plays 
a central role in major histocompatibility complex class 
I (MHC I) mediated antigen presentation, functioning of 
dendritic cells, antibody production and cross priming of 
immune cells[20]. Suppression of this glycoprotein may be 
one mechanism by which the pathogen neutralizes the host 
immune response.
  The relationship between O. tsutsugamushi infection and 
HIV is of interest in current context. Watt et al[21] for the 
first time demonstrated that HIV viral load fell during acute 
infection with scrub typhus in HIV positive individuals and 
serum samples from patients with acute typhus suppressed 
HIV-1 in vitro. A plausible hypothesis was that a humoral 
factor induced by acute infection suppressed HIV activity. 
However the authors failed to identify this molecule though 
there were several suggestions[22]. Several queries were 
raised regarding the methodology (small sample size, viral 
load measurements etc.)[23,24] of this initial observation. 
Another follow up study however, has shown further 
supportive evidence. Infusion of plasma from patients 
with mild acute scrub typhus, reduced viral loads in 7 out 
of 10 patients with HIV-1 infection. The beneficial effect 
was observed up to 8 weeks after a single transfusion. 
However, the in vivo impact of donor plasma was not seen 
in all HIV infected patients[25]. Several hypotheses have 
been developed to explain these observations including 
an inhibitory antibody mediated response, restriction of 
syncytia forming/maintenance of non syncytia inducing 
phenotypes of virus and specific activity against certain 
strains of the HIV virus[26]. However the actual mechanism 
for this observation remains an enigma. 
4. Clinical manifestations
  The incubation period of O. tsutsugamushi in humans is 
around 10-12 d (can vary between 6-21 d)[13]. The clinical 
manifestations vary in severity from a mild febrile illness to a 
severe potentially fatal disease with multi organ dysfunction 
syndrome (MODS). The typical systemic features of 
infection are well known and include fever, gastrointestinal 
disturbances, malaise, cough, myalgia and headache[13]. A 
maculopapular rash starting on the trunk and spreading in to 
the limbs is seen towards the end of the first week (since the 
onset of fever)[13]. Regional lymphadenopathy is commonly 
observed. 
  Another significant finding is an eschar at the bite site 
which is almost diagnostic. The prevalence of eschars in 
patients diagnosed with scrub typhus have been reported 
as between 7%-80%[27-29]. Difficulty in detecting small 
eschars in dark skinned individuals, eschar inducing 
capacity of different strains of O. tsutsugamushi and atypical 
appearance of eschars in areas of damp and moist skin 
may be the reason for this difference. The eschar starts as 
a small papule that enlarges and subsequently undergoes 
central necrosis to turn black. The common sites for finding 
an eschar are groin, axilla, waist and other exposed parts 
of the body. Kim et al[27] for the first time showed different 
patterns of eschar distribution in males and females. 
Authors attributed this to differences in skin folds, clothing 
and pressure points created by undergarments. The front of 
the chest and the area within 30 cm from the umbilicus were 
common sites for both sexes while lower limbs and back 
were also common areas for males and females respectively. 
However, the findings in other communities, where there are 
different gendered patterns in clothing and outdoor activities 
may reveal different results.
  From the second week onwards, a proportion of patients 
(especially those with untreated disease) will show 
evidence of systemic infection. This stage of illness 
can attack different organ systems such as the central 
nervous system (acute diffuse encephalomyelitis, 
encephalopathy, meningitis, deafness, cranial nerve palsies, 
eye manifestations)[30-35], cardiovascular system (rhythm 
abnormalities, myocardial involvement with congestive heart 
failure, vasculitis)[13,36,37], renal system (acute renal failure)
[38-40], respiratory system (Interstitial pneumonia and acute 
respiratory distress syndrome)[41-44] and gastrointestinal 
system (alterations in liver functions, pancreatitis, diarrhoea)
[45-48]. Sometimes MODS ensues[10,40,49]. Due to the wide 
variation in the clinical manifestations, the diagnosis of 
scrub typhus is often missed or made late. 
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5. Scrub typhus in pregnancy
  The impact of scrub typhus in pregnancy is less 
explored. In a case series of eight patients treated for 
acute scrub typhus during pregnancy (confirmed by 
indirect immunofluorescence assay), Kim et al[50] describe 
a healthy outcome for both mothers and babies (without 
any congenital infections or malformations). All patients 
had an uncomplicated illness and gestational age at 
presentation varied between 10-29 weeks.  However poor 
foetal outcome has been reported; Mathai et al[51] report 
of four women with scrub typhus in the second trimester, 
treated with ciprofloxacin, who all had miscarriages or 
still births. In another case report, an infected woman was 
treated with chloramphenicol successfully at 29 weeks of 
gestation. However the baby was born prematurely and 
died subsequently (no vertical transmission demonstrated)
[52]. Neonatal scrub typhus has been reported in two 
instances with cord blood being positive for IgM[53,54]. Acute 
scrub typhus can be transmitted vertically but congenital 
malformation due to infection per se, has not been 
demonstrated.
6. Prognostic indicators
  Given the significant sequelae of infection, early 
identification of indicators for a worse prognosis will help in 
the management. However the literature on such indicators 
is limited and in studies where such factors are identified, 
the sample sizes are too small to come to solid conclusions. 
Lai  et  al [55] comparing 18 patients with delayed 
defervescence against 88 patients with fast recovery, cite 
absence of headache, relative bradycardia and jaundice as 
predictors of delayed defervescence. However, this study 
analyzed patients with scrub typhus, murine typhus and 
Q fever together and only 7 patients with scrub typhus 
had delayed defervescence. It is not clear whether these 
predictors differed for individual infections. In addition, 
delayed fever can be attributed to many other factors such 
as resistant strains and the choice of antibiotics (all these 
patients were treated with doxycycline). These findings have 
not been confirmed by other investigators. 
  Sonthayanon et al[56] have demonstrated that higher DNA 
loads at admission are positively correlated with mortality 
and a longer duration of illness (P<0.001).  While this 
is an interesting concept directly correlating bacterial 
burden with clinical outcome, its applicability in resource 
limited settings is doubtful because of the cost factor. In a 
retrospective epidemiological study, Lee et al[57] describes 
absence of an eschar, higher APACHE II scores and an event 
of ICU admission as independent risk factors associated 
with fatality (n=297, deaths=18). This shows a conflict in 
evidence with the previous study by Sonthayanon et al, who 
showed that the presence of an eschar was positively and 
significantly correlated with higher DNA loads at admission 
which in turn was associated with a fatal outcome. Due to 
such conflicts in evidence, gaps in data and small sizes 
of samples, it is difficult to establish clear prognostic 
indicators. This is an area for further research.
7. Conclusion
  Scrub typhus is an important infectious disease with 
a potentially fatal outcome. Apart from the classical 
presentation as an acute febrile illness, many other unusual 
clinical manifestations are reported.  In countries where 
other febrile illnesses are also commonly seen, awareness 
of these unusual manifestations may alert the clinician to 
a diagnosis of scrub typhus, enabling early administration 
of appropriate antibiotics. Experience with the disease 
in pregnancy is limited to a few case reports but vertical 
transmission has been demonstrated. Prognostic indicators 
for severe disease cannot be established with the available 
evidence due to limited sample sizes and conflicting results.
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